InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the complete record of transactions filed by Kolean Chad J. Director active across 1 company, notably Cellectar Biosciences, Inc.. Aggregated, 1 reports have been logged. Activity tracked since 8 December 2023. The latest transaction was filed on 8 December 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration